🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants

Recruitingn/aAges 7 Days - 5 YearsAllMcGill University Health Centre/Research Institut…
NCT04114435 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Pulmonary vascular disease and cardiac performance in extreme preterm infants: A prospective cross-sectional study

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Infants born at \<29 weeks' gestational age admitted to the NICU * All infants born at \<29 weeks' gestational age followed at MCH clinic after an admission in the NICU for prematurity \<29 weeks Exclusion Criteria: * Congenital heart disease (except an atrial (ASD) or ventricular septal defect (VSD), or a patent ductus arteriosus (PDA)) * Congenital severe lung or airway malformation (choanal atresia, trachea-esophageal fistula or congenital pulmonary airway malformation) * Genetic disorder (Trisomy 21).
💊

What it tests

  • Echocardiography
📍

Where

1 site
Mcgill University Health Centre
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy